Ujjivan Small Finance Bank Limited moves to reshape its capital structure

• Issue price: Rs 64.73 per share. The notice states that the price was determined under Chapter V of the SEBI (ICDR) Regulations, using 14 October 2026 as the relevant date, but it does not disclose the numerical floor price. Therefore, the exact premium or discount to the floor price cannot be calculated from the filing. ^[1]
• Equity dilution: The proposed issue of 63,191,619 shares against post-issue equity of 2,016,156,539 shares implies 3.13% dilution for existing shareholders on an undiluted basis. Existing shareholders would retain approximately 96.87% post-allotment. Calculation: 63,191,619 ÷ 2,016,156,539. ^[2]

The 3.13% figure excludes the separate effect of outstanding ESOP options; on the filing’s fully diluted post-issue base, the preferential shares represent approximately 3.05%. ^[2]

The EGM notice does not earmark a separate rupee amount specifically for Tier-1 CAR. It states that the entire proposed preferential issue—up to Rs 409.04 Crores—is intended to strengthen capital adequacy, create growth headroom and fund strategic ambitions. Therefore, Rs 409.04 Crores is the maximum gross equity infusion relevant to Tier-1 capital strengthening, subject to full subscription and completion of the issue; a narrower Tier-1 allocation is not separately disclosed. ^[3]

Effect on leverage capacity

• Ujjivan SFB’s standalone CET1 ratio was 19.5% at Q2 FY27. ^[4]
• Its standalone total equity was Rs 7,531.9 Crores at Q2 FY27. ^[5]
• The proposed issue equals approximately 5.43% of that Q2 FY27 equity base, calculated as Rs 409.04 Crores divided by Rs 7,531.9 Crores. This is a balance-sheet equity uplift, not a debt increase.
• The infusion should therefore increase the capital available to support additional risk-weighted assets and reduce the risk of capital becoming the immediate constraint on loan growth. However, the notice does not provide risk-weighted assets, the post-issue CET1 ratio, or the bank’s target capital buffer; hence the precise additional lending or leverage capacity for FY27 cannot be calculated from the disclosed information.

Analytical conclusion: the issue provides a meaningful capital cushion—roughly 5.4% against the latest reported book-equity base—but it does not mechanically translate into 5.4% additional loan growth. The actual leverage capacity will depend on the capital ratio applied to incremental risk-weighted assets, portfolio risk weights, retained earnings, and the timing of allotment during FY27.

The proposed Ujjivan SFB issue is meaningful but not unusually large in absolute terms. At up to Rs 409.04 Crores, it is about Rs 91 Crores, or 18.2%, below Equitas SFB’s Rs 500 Crores NCD programme announced in September 2026. However, the comparison is not like-for-like: Ujjivan is raising permanent common equity, while Equitas is issuing subordinated debt. Ujjivan’s transaction is also still subject to shareholder approval at the proposed 13 November 2026 EGM. ^{[3] [6] [7]}

Peer capital-raising evidence

N/D means that transaction terms are not available in the cited evidence; it does not establish that no fund-raising occurred.

On the identifiable transactions, Ujjivan’s issue is smaller than Equitas’s nominal Rs 500 Crores programme but more accretive to loss-absorbing capital, because it is common equity rather than an interest-bearing instrument. The available evidence does not support describing this as a broad, peer-wide equity-raising cycle. Utkarsh’s 61.5% increase in reported equity share capital warrants investigation, but it cannot be classified as a specific last-12-month capital raise without the underlying filing or transaction terms.

Does this change Ujjivan’s funding strategy?

Yes, it changes the funding mix, but it does not amount to a wholesale move away from internal accruals.

• Ujjivan’s preferential-issue notice states that, since its last equity infusion through a QIP in FY2022–23, strategic expansion had been funded entirely through internal accruals and retained earnings. The proposed issue therefore marks a move from an internally funded model to a blended model combining retained earnings with selective external equity. ^[14]
• The raise is modest relative to the broader authorization: Rs 409.04 Crores represents about 20.5% of the Rs 2,000 Crores equity-raising authority approved by shareholders. ^{[14] [3]}
• Against Ujjivan’s reported Q2 FY27 total equity of Rs 7,531.9 Crores, the proposed issue is approximately 5.4%, a material capital addition but not a balance-sheet reset. ^{[5] [3]}
• The raise is equivalent to approximately 59% of FY26 PAT of Rs 692.63 Crores, so it is sizeable relative to one year’s earnings generation, even though it is smaller relative to the existing capital base. ^{[15] [3]}
• The stated objective is to strengthen capital adequacy and create headroom for sustained growth, while Ujjivan is shifting toward secured lending. ^{[3] [14]} This is consistent with using external equity to support a larger balance sheet and portfolio diversification rather than waiting exclusively for retained earnings to compound.
• Internal capital generation remains relevant: Ujjivan’s FY26 annual-report disclosure attributes the increase in net worth from Rs 6,083 Crores to Rs 6,816 Crores to sustained profitability and internal capital generation, while reporting a FY26 capital adequacy ratio of 21.14%. ^[16] The bank has also continued to use deposits and securitisation as funding channels; its securitisation pool was increased by Rs 500 Crores in October 2026. ^[17]

Conclusion: the issuance is best viewed as a tactical broadening of Ujjivan’s capital-formation toolkit, not a replacement of internal accruals. The key strategic change is that management is now willing to bring in external common equity ahead of future growth opportunities, particularly secured lending, after several years of relying primarily on retained earnings.